Oxurion NV (LTS:0G99) PB Ratio: (As of Jul. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0G99 Oxurion NV LTS:0G99
9 GF Score
Price €0.27
GF Value €0.91
! 7 Warning Signs
View Full Analysis

What is Oxurion NV PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-13), Oxurion NV's share price is €0.273. Oxurion NV's Book Value per Share for the quarter that ended in Dec. 2025 was €-0.21. Hence, Oxurion NV's PB Ratio of today is .

The historical rank and industry rank for Oxurion NV's PB Ratio or its related term are showing as below:

During the past 13 years, Oxurion NV's highest PB Ratio was 4.50. The lowest was 0.59. And the median was 1.57.

LTS:0G99's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.93
* Ranked among companies with meaningful PB Ratio only.

During the past 3 years, the average Book Value Per Share Growth Rate was 87.70% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Oxurion NV was 87.70% per year. The lowest was -42.50% per year. And the median was 10.85% per year.

Back to Basics: PB Ratio


Oxurion NV  (LTS:0G99) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Oxurion NV PB Ratio Related Terms


Oxurion NV PB Ratio Historical Data

* Premium members only.

The historical data trend for Oxurion NV's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxurion NV PB Ratio Chart

Oxurion NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oxurion NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LTS:0G99 vs VRTX, REGN, ALNY: PB Ratio Comparison

For the Biotechnology subindustry, Oxurion NV's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxurion NV PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxurion NV's PB Ratio distribution charts can be found below:

* The bar in red indicates where Oxurion NV's PB Ratio falls into.


LTS:0G99
9GF Score
Oxurion NV LTS:0G99
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oxurion NV PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Oxurion NV's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=0.273/-0.206
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Is Oxurion NV (LTS:0G99) Overvalued in 2026?

Based on GuruFocus' analysis, Oxurion NV stock appears to be undervalued. The current stock price of €0.27 is trading 70% below its estimated GF Value™ of €0.91.

Key valuation signals for LTS:0G99:

  • PB Ratio:
  • GF Value™: €0.91 vs. price of €0.27 (70% below fair value)
  • GF Score™: 9/100 with 7 warning signs

No single metric tells the full story. See the LTS:0G99 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oxurion NV Business Description

Other Exchanges TG40:GermanyOXUR:Belgium
Address Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a holding company specializing in acquiring and integrating clinical research services companies (CROs) covering the full clinical research value chain across Europe.
9GF Score

Get the complete analysis for LTS:0G99

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.91
GF Value